These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 17440813)

  • 1. Estimation of likely cancer cure using first- and second-order product densities of population balance models.
    Sherer E; Hannemann RE; Rundell A; Ramkrishna D
    Ann Biomed Eng; 2007 Jun; 35(6):903-15. PubMed ID: 17440813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling embryogenesis and cancer: an approach based on an equilibrium between the autostabilization of stochastic gene expression and the interdependence of cells for proliferation.
    Laforge B; Guez D; Martinez M; Kupiec JJ
    Prog Biophys Mol Biol; 2005 Sep; 89(1):93-120. PubMed ID: 15826673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The average number of alpha-particle hits to the cell nucleus required to eradicate a tumour cell population.
    Roeske JC; Stinchcomb TG
    Phys Med Biol; 2006 May; 51(9):N179-86. PubMed ID: 16625028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A minimal model of tumor growth inhibition.
    Magni P; Germani M; De Nicolao G; Bianchini G; Simeoni M; Poggesi I; Rocchetti M
    IEEE Trans Biomed Eng; 2008 Dec; 55(12):2683-90. PubMed ID: 19126447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A two-stage stepwise estimation procedure.
    Chen JT
    Biometrics; 2008 Jun; 64(2):406-12. PubMed ID: 18325070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A step toward optimization of cancer therapeutics. Physiologically based modeling of circadian control on cell proliferation.
    Clairambault J
    IEEE Eng Med Biol Mag; 2008; 27(1):20-4. PubMed ID: 18270046
    [No Abstract]   [Full Text] [Related]  

  • 7. Hazard function for cancer patients and cancer cell dynamics.
    Horová I; Pospísil Z; Zelinka J
    J Theor Biol; 2009 Jun; 258(3):437-43. PubMed ID: 18634801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of resonance chemotherapy in leukemia treatment via multi-staged population balance models.
    Sherer E; Hannemann RE; Rundell A; Ramkrishna D
    J Theor Biol; 2006 Jun; 240(4):648-61. PubMed ID: 16430925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A microenvironment based model of antimitotic therapy of Gompertzian tumor growth.
    Kozusko F; Bourdeau M; Bajzer Z; Dingli D
    Bull Math Biol; 2007 Jul; 69(5):1691-708. PubMed ID: 17577604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-volume simulation during radiotherapy for head-and-neck cancer using a four-level cell population model.
    Chvetsov AV; Dong L; Palta JR; Amdur RJ
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):595-602. PubMed ID: 19596173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A sensitive assay for the evaluation of cytotoxicity and its pharmacologic modulation in human solid tumor-derived cell lines exposed to cancer-therapeutic agents.
    Mirzayans R; Andrais B; Scott A; Tessier A; Murray D
    J Pharm Pharm Sci; 2007; 10(2):298s-311s. PubMed ID: 17718933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the analysis of count data of birth-and-death process type: with application to molecularly targeted cancer therapy.
    Liu H; Beckett LA; DeNardo GL
    Stat Med; 2007 Feb; 26(5):1114-35. PubMed ID: 16755532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A stochastic model of tumor angiogenesis.
    Mohammadi B; Haghpanah V; Larijani B
    Comput Biol Med; 2008 Sep; 38(9):1007-11. PubMed ID: 18722598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy may be delivered based on an integrated view of tumour dynamics.
    Ribba B; You B; Tod M; Girard P; Tranchand B; Trillet-Lenoir V; Freyer G
    IET Syst Biol; 2009 May; 3(3):180-90. PubMed ID: 19449978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the effectiveness of selected non-steroidal anti-inflammatory drugs and their derivatives against cancer cells in vitro.
    Andrews P; Zhao X; Allen J; Li F; Chang M
    Cancer Chemother Pharmacol; 2008 Feb; 61(2):203-14. PubMed ID: 17447067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stochastic modeling of cellular colonies with quiescence: an application to drug resistance in cancer.
    Komarova NL; Wodarz D
    Theor Popul Biol; 2007 Dec; 72(4):523-38. PubMed ID: 17915274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal controls for a model with pharmacokinetics maximizing bone marrow in cancer chemotherapy.
    Ledzewicz U; Schättler H
    Math Biosci; 2007 Apr; 206(2):320-42. PubMed ID: 16197967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of single-agent chemotherapy compared with combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer.
    Di Maio M; Chiodini P; Georgoulias V; Hatzidaki D; Takeda K; Wachters FM; Gebbia V; Smit EF; Morabito A; Gallo C; Perrone F; Gridelli C
    J Clin Oncol; 2009 Apr; 27(11):1836-43. PubMed ID: 19273711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Observer-based techniques for the identification and analysis of avascular tumor growth.
    Cacace F; Cusimano V; Di Paola L; Germani A
    Math Biosci; 2011 Dec; 234(2):147-53. PubMed ID: 22023728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Making sense of cancer chemotherapy.
    Holmes S
    Nurs Times; 1996 Sep 4-10; 92(36):42-3. PubMed ID: 8868768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.